Literature DB >> 9808528

Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia.

G Y Ho1, P R Palan, J Basu, S L Romney, A S Kadish, M Mikhail, S Wassertheil-Smoller, C Runowicz, R D Burk.   

Abstract

Genital human papillomavirus (HPV) infection is the major causal factor of cervical intraepithelial neoplasia (CIN). The potential role of nutrition as an additional, independent risk factor for CIN has not been appropriately addressed in the context of HPV. This case-control study evaluated the etiologic role of HPV in terms of viral type and load and examined the association between CIN and plasma levels of micronutrients adjusting for HPV. Cases (n = 378) with histo-pathologically confirmed CIN and controls (n = 366) with no history of abnormal Pap smears were recruited from colposcopy and gynecology clinics, respectively. Risk of CIN was significantly increased among women who were infected with multiple HPV types (odds ratio [OR] = 21.06), a high viral load (OR = 13.08) and HPV 16 (OR = 62.49). After adjusting for HPV positivity and demographic factors, there was an inverse correlation between plasma alpha-tocopherol and risk of CIN (OR = 0.15). Plasma ascorbic acid was protective at a high level of > or = 0.803 mg/dl (OR = 0.46). CIN was not associated with plasma retinol and beta-carotene levels. The effect of genital HPV infection on CIN development is highly influenced by oncogenic viral type and high viral load. Vitamins C and E may play an independent protective role in development of CIN that needs to be confirmed in prospective studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808528     DOI: 10.1002/(sici)1097-0215(19981123)78:5<594::aid-ijc11>3.0.co;2-b

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Infection with Human Papillomavirus: Update on Epidemiology, Diagnosis, and Treatment.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Risk factors for persistent cervical intraepithelial neoplasia grades 1 and 2: managed by watchful waiting.

Authors:  Gloria Y F Ho; Mark H Einstein; Seymour L Romney; Anna S Kadish; Maria Abadi; Magdy Mikhail; Jayasri Basu; Benjamin Thysen; Laura Reimers; Prabhudas R Palan; Shelly Trim; Nafisseh Soroudi; Robert D Burk
Journal:  J Low Genit Tract Dis       Date:  2011-10       Impact factor: 1.925

3.  Enhanced enzyme-linked immunosorbent assay for detection of antibodies to virus-like particles of human papillomavirus.

Authors:  Yevgeniy Y Studentsov; Mark Schiffman; Howard D Strickler; Gloria Y F Ho; Yuk-Ying Susana Pang; John Schiller; Rolando Herrero; Robert D Burk
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

4.  Kinetics of DNA load predict HPV 16 viral clearance.

Authors:  M Marks; P E Gravitt; U Utaipat; S B Gupta; K Liaw; E Kim; A Tadesse; C Phongnarisorn; V Wootipoom; P Yuenyao; C Vipupinyo; S Rugpao; S Sriplienchan; D D Celentano
Journal:  J Clin Virol       Date:  2011-03-09       Impact factor: 3.168

5.  Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.

Authors:  Rachel L Winer; Tiffany G Harris; Long Fu Xi; Kathrin U Jansen; James P Hughes; Qinghua Feng; Carolee Welebob; Jesse Ho; Shu-Kuang Lee; Joseph J Carter; Denise A Galloway; Nancy B Kiviat; Laura A Koutsky
Journal:  J Med Virol       Date:  2009-04       Impact factor: 2.327

6.  Genetic variants in TAP are associated with high-grade cervical neoplasia.

Authors:  Mark H Einstein; Suzanne Leanza; Lydia G Chiu; Nicolas F Schlecht; Gary L Goldberg; Bettie M Steinberg; Robert D Burk
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

7.  Escharotic Treatment for ECC-positive CIN3 in Childbearing Years: A Case Report.

Authors:  Kimberly Windstar; Corina Dunlap; Heather Zwickey
Journal:  Integr Med (Encinitas)       Date:  2014-04

8.  No association of TAP1 and TAP2 genes polymorphism with risk of cervical cancer in north Indian population.

Authors:  Dor Mohammad Kordi Tamandani; Ranbir Chander Sobti; Mohammad Shekari; Seyd Ali Husseini; Vanita Suri
Journal:  J Assist Reprod Genet       Date:  2009-03-05       Impact factor: 3.412

9.  Does pretreatment HPV viral load correlate with prognosis in patients with early stage cervical carcinoma?

Authors:  Yong Mi Kim; Jin Young Park; Kyung Mi Lee; Tae-Wook Kong; Seung-Chul Yoo; Woo Young Kim; Jong-Hyuck Yoon; Suk-Joon Chang; Ki-Hong Chang; Hee-Sug Ryu
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

10.  Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III.

Authors:  Mark H Einstein; Anna S Kadish; Robert D Burk; Mimi Y Kim; Scott Wadler; Howard Streicher; Gary L Goldberg; Carolyn D Runowicz
Journal:  Gynecol Oncol       Date:  2007-06-22       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.